A highly potent extended half-life antibody as a potential RSV vaccine surrogate for all infants.
Zhu Q, McLellan JS, Kallewaard NL, Ulbrandt ND, Palaszynski S, Zhang J, Moldt B, Khan A, Svabek C, McAuliffe JM, Wrapp D, Patel NK, Cook KE, Richter BWM, Ryan PC, Yuan AQ, Suzich JA.
Zhu Q, et al. Among authors: cook ke.
Sci Transl Med. 2017 May 3;9(388):eaaj1928. doi: 10.1126/scitranslmed.aaj1928.
Sci Transl Med. 2017.
PMID: 28469033